Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities (Q35082495)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
scientific article

    Statements

    Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities (English)
    0 references
    0 references
    0 references
    0 references
    Lars Möllgård
    Leonie Saft
    Marianne Bach Treppendahl
    Ingunn Dybedal
    Jan Maxwell Nørgaard
    Jan Astermark
    Elisabeth Ejerblad
    Hege Garelius
    Inge Høgh Dufva
    Monika Jansson
    Martin Jädersten
    Lars Kjeldsen
    Olle Linder
    Lars Nilsson
    Hanne Vestergaard
    Anna Porwit
    Kirsten Grønbæk
    Eva Hellström-Lindberg

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit